Listen to Gynecologic Oncology

Editor’s Choice: Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study Editorial: Sentinel lymph node biopsy in high-risk endometrial cancer: The dénouement Hosted by: Gregg Nelson, MD, Editor of Gynecologic Oncology Featuring : Sarah M. Bjørnholt, MD, Aarhus University Hospital, Denmark Sean Dowdy, MD, Mayo Clinic, USA Chec...

Editor’s Choice: Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers Editorial:  The importance of family-focused care in the setting of advanced gynecological cancers Hosted by: Sean Dowdy, MD, Associate Editor of Gynecologic Oncology Featuring : Rachel A. Pozzar, PhD, RN, Dana Farber Cancer Institute and Harvard Medical School Allison J. Appleba...

Editor’s Choice: Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma Editorial:  What's in your “lunchbox”? Sandwich versus sequential chemotherapy and irradiation for advanced endometrial...

Editor’s Choice: Associations between modifiable lifestyle factors and health-related quality of life among endometrial carcinoma survivors - A cross-sectional study Editorial:  Optimising endometrial cancer survivorship through lifestyle change Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring : Ane Gerda Z. Eriksson, MD, Oslo University Hospital, Norway  S....

Editor’s Choice: Use of a mobile health patient engagement technology improves perioperative outcomes in gynecologic oncology patients Editorial: How does mobile health engagement technology help gynecologic oncology patients recover from surgery, affect health equity, and impact healthcare costs? Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring : Teresa K.L....

Editor’s Choice: Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology Featuring : Kathleen N. Moore, MD, GOG-F and Stephenson Cancer Center at the University of Oklahoma Health...

Editor’s Choice: Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis? Editorial: Universal thromboprophylaxis in ovarian cancer patients before and after surgery? Hosted by: David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology Featuring : Amanika Kumar, MD, Mayo Clinic  Laura Hav...

Editor’s Choice: Improving genetic testing following abnormal mismatch repair immunohistochemistry results in endometrial cancer Editorial: Universal testing – Should it be that hard? Probably. If you're doing it right Hosted by: Gregg Nelson, MD, PhD, Editor of Gynecologic Oncology Featuring : Bhavana Pothuri, MD, NYU Perlmutter Cancer Center Leigha Senter, MS, CGC, The Ohio State University...

Editor’s Choice: Detection of endometrial cancer using tampon-based collection and methylated DNA markers Editorial: Early detection of endometrial cancer Hosted by: Dineo Khabele, MD, Associate Editor of Gynecologic Oncology Featuring: Jamie N. Bakkum-Gamez, MD, Mayo Clinic Jonathan C. Dudley, MD, The Johns Hopkins University School of Medicine Check out more content on the journal's homepag...

Tyrosine kinase inhibitor toxicities: A society of gynecologic oncology review and recommendations Hosted by: Róisín O’Cearbhaill, MD, Gynecologic Medical Oncologist, Memorial Sloan Kettering Cancer Center, New York Featuring: BJ Rimel, MD, Gynecologic Oncologist, Cedars-Sinai Medical Center Erin Crane, MD, MPH, Gynecologic Oncologist, Levine Cancer Institute Vicky Makker, MD, Medical Oncologist,...

Editor’s Choice: Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update Editorial:  Gynecologic oncology surgery – Ready for the next step in ERAS Hosted by: Amanda Nickles Fader, MD, Editor of Gynecologic Oncology Featuring: Gregg Nelson, MD, PhD, University of Calgary Sean Dowdy, MD, Mayo Clinic College of Medicine...

Editor’s Choice: What's in it for me?: A value assessment of gynecologic cancer clinical trials for Black women Editorial:  Achieving diversity in clinical trial enrollment by reducing burden and increasing value: A patient-centered approach Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology Featuring: Ann Oluloro, MD, MPH, University of Washington Eloise Chapman-Davis,...

Editor’s Choice: Doubling down on the future of gynecologic oncology: The SGO future of the profession summit report Editorial:  “The times they are a-changin’” – And how are we managing? Hosted by: David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology Featuring: Stephanie V. Blank, MD, Icahn School of Medicine at Mount Sinai Warner K. Huh, MD, FACOG, FACS, University of Alabama B...

Editor’s Choice: Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level – A Memorial Sloan Kettering Cancer Center study Editorial: Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: The evolution of a “pelvic” surgeon Hosted by: Warner K. Huh, MD, FACOG, FACS, Deputy Editor of  Gynecologic Oncology Featuring: Ry...

Editor’s Choice: Cervical cancer geographical burden analyzer: An interactive, open-access tool for understanding geographical disease burden in patients with recurrent or metastatic cervical cancer Editorial: Targeting our efforts: the contribution of an open-access tool to assess geographic distribution of recurrent and metastatic cervical cancer Hosted by: Wendy R. Brewster, MD, PhD, Deputy Edi...

Molecular testing for endometrial cancer: An SGO clinical practice statement Hosted by:   Kari Hacker, MD, PhD, Gynecologic Oncologist, New York University Langone Health   Featuring: Christine Walsh, MD, MS, Gynecologic Oncologist, University of Colorado Carolyn McCourt, MD, Gynecologic Oncologist, Washington University School of Medicine Kari Hacker, MD, PhD, is joined by Christine Walsh, MD, MS...

Editor’s Choice: Sentinel lymph node mapping in patients with endometrial hyperplasia: A practice to preserve or abandon? Editor’s Choice: Is sentinel lymph node assessment useful in patients with a preoperative diagnosis of endometrial intraepithelial neoplasia? Editorial: Routine SLN biopsy for endometrial intraepithelial neoplasia: A pragmatic approach or over-treatment? Hosted by: Gregg Nelson...

Article: SGO and the elephant that is still in the room: Wellness, burnout and gynecologic oncology Hosted by: Gregg Nelson, MD, PhD, Editor of Gynecologic Oncology Featuring: Brittany A. Davidson, MD, Duke University David M. Kushner, MD, UW School of Medicine and Public Health Check out more content on the journal's homepage  at https://www.gynecologiconcology-online.net

Editor’s Choice : Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma Editorial : The rapid evolution of PARP inhibitor therapy for advanced ovarian cancer: Lessons being learned and new questions emerging from phase 3 trial long-term outcome data Hosted by : Ursula Matulonis, MD, Associate...

Editor’s Choice: Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival Editorial: Low grade serous ovarian cancer: Unpicking drivers of outcome Hosted by: Amanda Nickles Fader, MD, Associate Editor of Gynecologic Oncology Featuring: David M. Gershenson, MD, The University of Texas MD Anderson C...

Editor’s Choice: Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe Editorial: When is it safe to omit contralateral groin management in unilateral sentinel node-positive early stage vulvar cancer? Hosted by: S. Diane Yamada, MD, Deputy Editor of Gynecologic Oncology Featuring: Maaike Oonk, M...

Editor’s Choice: Preoperative assessment using the five-factor modified frailty index: A call for standardized preoperative assessment and prehabilitation services in gynecologic oncology Editorial: Answering the call: Are we ready for action on frailty in gynecologic oncology? Hosted by: Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology Featuring: Mariam M. AlHilli, MD Gynecologi...

Editor’s Choice: The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancer Editorial: Complications associated with cytoreductive surgery for advanced ovarian cancer: Surgical timing and surmounting obstacles Hosted by: Warner K. Huh, MD, FACOG, FACS, Deputy Editor of Gynecologic Oncology Featuring: Pr Alejandra Martinez, In...

Editor’s Choice: Immunotherapy toxicities: An SGO clinical practice statement Hosted by: Leslie Clark, MD, Gynecologic Oncologist, University of North Carolina in Chapel Hill Featuring: Róisín O’Cearbhaill, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center Ramez Eskander, MD, Gynecologic Oncologist, University of California San Diego Dr. Leslie Clark presents a patient case to frame a...

Editor’s Choice: Cardiovascular conditions and obesity among gynecologic cancer survivors: Results from the 2020 behavioral risk factor surveillance system survey Editorial: The intersection of gynecologic cancer, obesity, and cardiovascular disease Hosted by: Jose Alejandro Rauh-Hain, MD, MPH, Associate Editor of Gynecologic Oncology Featuring: Steven S. Coughlin, MD, Augusta University Daniel Ad...